<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04976894</url>
  </required_header>
  <id_info>
    <org_study_id>2019-11-095</org_study_id>
    <nct_id>NCT04976894</nct_id>
  </id_info>
  <brief_title>Korean Stroke Cohort for Functioning and Rehabilitation-II</brief_title>
  <acronym>KOSCO-II</acronym>
  <official_title>Korean Stroke Cohort for Functioning and Rehabilitation-II</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Korean Stroke Cohort for functioning and rehabilitation (KOSCO)-II is a large, multi-centre&#xD;
      prospective cohort study for all acute first-ever stroke patients admitted to participating&#xD;
      hospitals in nine distinct areas of Korea. This study is designed as a 10-year, longitudinal&#xD;
      follow-up investigating the residual disabilities, activity limitations, and quality of life&#xD;
      issues arising in patients suffering from first-ever stroke as previous similar stroke cohort&#xD;
      with KOSCO. The main objectives of this study are to identify and compare the factors that&#xD;
      influence residual disability and long-term quality of life in first-ever acute stroke&#xD;
      patients with KOSCO. The secondary objectives of this study are to determine and compare the&#xD;
      risk of mortality and recurrent vascular events in first-ever acute stroke patients with&#xD;
      KOSCO. Investigators will investigate longitudinal health behaviors and patterns of&#xD;
      healthcare utilization, including stroke rehabilitation care. Investigators will also&#xD;
      investigate the long-term health status, mood, and quality of life in stroke patient&#xD;
      caregivers. In addition, investigators will identify baseline and ongoing characteristics&#xD;
      that are associated with secondary outcomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2030</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Change in Korean modified Barthel Index</measure>
    <time_frame>3 months, 6 months, 12 months, 18 months, 24 months, 36 months, 48 months, 60 months, 72 months, 84 months, 96 months, 108 months after stroke onset.</time_frame>
    <description>measurement for activities of daily living Minimum: 0, Maximum: 100 Higher scores means a better.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Euro Quality of Life-5 Dimensions measurement for quality of life</measure>
    <time_frame>3 months, 6 months, 12 months, 18 months, 24 months, 36 months, 48 months, 60 months, 72 months, 84 months, 96 months, 108 months after stroke onset.</time_frame>
    <description>measurement for quality of life Minimum: 0, Maximum: 1 Higher scores means a better.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Functional Independence Measurement</measure>
    <time_frame>3 months, 6 months, 12 months, 18 months, 24 months, 36 months, 48 months, 60 months, 72 months, 84 months, 96 months, 108 months after stroke onset.</time_frame>
    <description>measurement for activities of daily living Minimum: 0, Maximum: 126 Higher scores means a better.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Korean Mini-Mental State Examination</measure>
    <time_frame>7 days, 3 months, 6 months, 12 months, 18 months, 24 months, 36 months, 48 months, 60 months, 72 months, 84 months, 96 months, 108 months after stroke onset.</time_frame>
    <description>measurement for language function Minimum: 0, Maximum: 30 Higher scores means a better.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Korean Version of Frenchay Aphasia Screening Test</measure>
    <time_frame>7 days, 3 months, 6 months, 12 months, 18 months, 24 months, 36 months, 48 months, 60 months, 72 months, 84 months, 96 months, 108 months after stroke onset.</time_frame>
    <description>measurement for language function Minimum: 0, Maximum: 30 Higher scores means a better.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in modified Rankin Scale</measure>
    <time_frame>7 days, 3 months, 6 months, 12 months, 18 months, 24 months, 36 months, 48 months, 60 months, 72 months, 84 months, 96 months, 108 months after stroke onset</time_frame>
    <description>Measurement for disability. Range of total score 0 to 6. 0 is no disability at all and 6 is death. Therefore, greater value means worse functional status</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in American Speech-Language-Hearing Association National Outcome Measurement System Swallowing Scale</measure>
    <time_frame>7 days, 3 months, 6 months, 12 months, 18 months, 24 months, 36 months, 48 months, 60 months, 72 months, 84 months, 96 months, 108 months after stroke onset</time_frame>
    <description>Measurement for swallowing function. Range of scale is 0 to 7, and greater value means better function. For example, 7 means no swallowing difficulty at all.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Geriatric depression scale-short form</measure>
    <time_frame>3 months, 6 months, 12 months, 18 months, 24 months, 36 months, 48 months, 60 months, 72 months, 84 months, 96 months, 108 months after stroke onset</time_frame>
    <description>measurement for depression. The scale is 0 to 15. 0 is normal whereas 15 indicates severe depression.&#xD;
Minimum: 0, Maximum: 15. Lower scores means a better.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Functional Ambulatory Category</measure>
    <time_frame>7 days, 3 months, 6 months, 12 months, 18 months, 24 months, 36 months, 48 months, 60 months, 72 months, 84 months, 96 months, 108 months after stroke onset</time_frame>
    <description>measurement for gait function Minimum: 0, Maximum: 5 Higher scores means a better.</description>
  </primary_outcome>
  <enrollment type="Actual">2431</enrollment>
  <condition>Stroke</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>open</intervention_name>
    <description>open</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients with an acute first-ever stroke, admitted to the representative&#xD;
        hospitals in the nine distinct areas of Korea, will be asked to participate in the study.&#xD;
        Participating study centres are Samsung Medical Center, Seoul; Severance Hospital, Seoul;&#xD;
        Konkuk University Hospital, Seoul; Chungnam National University Hospital, Daejeon; Chonnam&#xD;
        National University Hospital, Gwangu; Pusan National University Yangsan Hospital, Yangsan;&#xD;
        Kyungpook National University Hospital, Deagu; Wonkwang University Hospital, Iksan; and&#xD;
        Jeju National University Hospital, Jeju.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  First-ever acute stroke (ischemic stroke or intracerebral hemorrhage) with&#xD;
             corresponding lesion and/or evidence of acute arterial occlusion on CT (A)- or&#xD;
             MRI/A-scan.&#xD;
&#xD;
          -  Age â‰¥ 19 years at onset of stroke.&#xD;
&#xD;
          -  Onset of symptoms within seven days prior to inclusion.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Transient ischemic attack.&#xD;
&#xD;
          -  History of stroke.&#xD;
&#xD;
          -  Traumatic intracerebral hemorrhage.&#xD;
&#xD;
          -  Not Korean.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Yun-Hee Kim, MD.,PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 16, 2021</study_first_submitted>
  <study_first_submitted_qc>July 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2021</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Yun-Hee Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Disability</keyword>
  <keyword>Function</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>Burden</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

